EMAP
Estudis en Medicaments en Atenció Primària (EMAP)

Group leader
avatar_investigadors.jpg
Rosa Morros Pedrós
rmorros@idiapjgol.org
avatar_grups_recerca.png

Projectes

Group projects

Servei Farmacovigilancia estudi: Exploratory, Phase 2 Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety and Impact on HIV-1 Reservoir of Baricitinib in Virologically Suppressed People With HIV-1

  • Principal investigators: Silvia Fernández García, Rosa Morros Pedrós
  • Code: 9F-0-00023-25
  • Start year: 2025

Plasma Exchange Therapy for Post- COVID-19 Condition: A Pilot, Randomized Double-Blind Study – PAX

  • Principal investigators: Silvia Fernández García, Rosa Morros Pedrós
  • Code: 9F22/006
  • Start year: 2022
  • Funders: Fundació Lluita contra la Sida. Hº Trias i Pujol